Abstract
Cancer immunotherapy has emerged as a groundbreaking treatment modality, utilizing the body’s immune system to target and eliminate cancer cells. Recent advancements in biotechnology have significantly enhanced the efficacy of cancer immunotherapies, with the development of novel immune checkpoint inhibitors, monoclonal antibodies, and personalized vaccines. This article reviews the latest innovations in cancer immunotherapy, focusing on biotechnology's role in the development of immune checkpoint inhibitors, engineered T-cell therapies, cancer vaccines, and the integration of biomarkers for personalized treatment strategies.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Dr. Olivia Grant, Dr. Robert Lee (Author)